Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy [Phase 3]
Phase 3 trial evaluating early palliative care in patients with metastatic upper gastrointestinal cancers treated with first-line chemothera…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 trial assessing paclitaxel albumin-stabilized nanoparticles with or without AZD1775 in previously untreated metastatic or unresect…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Efficacy and Safety of PARPi to Treat Pancreatic Cancer [Phase 2]
Phase 2 trial assessing PARP inhibitor efficacy and safety in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]
Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial of ascorbic acid combined with nab-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer [NA]
A completed clinical trial investigating preoperative biliary drainage in patients with resectable pancreatic or periampullary cancer; resul…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating anlotinib plus a PD-1 inhibitor as second-line therapy for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating irinotecan, oxaliplatin, and S1 in patients with advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX [Phase 3]
A Phase 3 trial comparing EndoTAG-1+GEM versus GEM in locally advanced or metastatic pancreatic adenocarcinoma after FOLFIRINOX failure has …
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for albumin-bound docetaxel in pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers [Phase 2]
Phase 2 trial of perioperative MVT-5873, a CA 19-9 epitope–targeting monoclonal antibody, in operable CA 19-9–producing pancreatic cancers, …
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating circulating tumor cells as tools for monitoring therapy response in patients with metastatic pancreatic ca…
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of gemcitabine plus nab-paclitaxel with or without FG-3019 in locally advanced, unresectable pancreatic cancer has completed…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 study evaluating cyclophosphamide, pembrolizumab, GVAX Pancreas Vaccine, and SBRT in locally advanced pancreatic cancer has complete…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer [NA]
Clinical trial update on radiopaque hydrogel spacer used during radiotherapy for pancreatic cancer; study completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating mFOLFIRINOX as first-line chemotherapy in Chinese patients with metastatic pancreatic cancer has completed…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients. [Phase 2]
Phase 2 trial assessing the efficacy and safety of postoperative mFOLFIRINOX as adjuvant chemotherapy for resectable pancreatic cancer in Ch…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer [Phase 1, Phase 2]
Phase 1b/2 trial evaluating tarextumab (OMP-59R5) in combination with nab-paclitaxel and gemcitabine in previously untreated stage IV pancre…
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating the combination of an anti-PD-1 antibody with chemotherapy in metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition [Phase 1]
A Phase 1 trial update investigates inhibiting SGLT2 as a potential approach for pancreatic cancer, with the study completed and results pos…
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer [Phase 3]
A Phase 3 trial evaluating mistletoe therapy in primary and recurrent inoperable pancreatic cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for durvalumab plus CV301 with maintenance chemotherapy in metastatic colorectal or pancreatic adenocarcinoma; study s…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer [Phase 2]
Phase II trial update investigating sequential AG and FOLFIRINOX as neoadjuvant therapy in patients with resectable pancreatic cancer.